Search
for
Sort by
Research 211–240 of 1000+
- Persistent or new symptoms 1 year after a single high dose of vitamin D3 in patients with moderate to severe COVID-19
- COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy
- Intermittent chronic telogen effluvium with an unusual dermoscopic finding following COVID ‐19
- Production of a 135-residue long N-truncated human keratinocyte growth factor 1 in Escherichia coli
- Not just thinning: A case of alopecia universalis after mild COVID-19
- Telogen effluvium caused by COVID-19 in Elmhurst, New York: report of a cohort and review
- Systematic investigation of a potential epidemiological and genetic association between male androgenetic alopecia and COVID‐19
- COVID-19 pandemic and teledermatology in low-income regions
- Increased risk of chronic fatigue and hair loss following COVID-19 in individuals with hypohidrotic ectodermal dysplasia
- A comment on psychological distress and women’s hair loss related to the COVID-19 pandemic
- COVID‐19 dermatological manifestations: results from the Mexican Academy of Dermatology COVID‐19 registry
- Hypoparathyroidism as the single major component for decades of autoimmune polyglandular syndrome type 1
- A response to “Male balding is a major risk factor for severe COVID-19”
- Reply to: “Comment on ‘Androgenetic alopecia present in the majority of patients hospitalized with COVID-19’”
- Viewpoint 1
- Alopecia in a 19-Month-Old Boy
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Examining the long‐term effects of COVID‐19 in surgical nurses: Case of Aegean Region
- Clinical Manifestation of Alopecia Areata After COVID-19 Infection or Vaccination
- Cutaneous manifestations associated with COVID-19 infection at a university hospital in eastern China
- Defining the short-term and long-term skin manifestations of COVID-19: insights after more than three years of the pandemic
- Assessment of chemokines MIP-1α and MIP-1 βin Iraqi women with polycystic ovarian syndrome
- Alopecia universalis after injection of messenger RNA COVID-19 vaccine. A case report
- Cutaneous Manifestations in Patients With COVID-19 Treated at a University Hospital in Southern Brazil
- Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin
- The Association Between Hair Loss and COVID-19: The Impact of Hair Loss After COVID-19 Infection on the Quality of Life Among Residents in Saudi Arabia
- Vitamins and their derivatives synergistically promote hair shaft elongation ex vivo via PlGF/VEGFR-1 signalling activation
- PO.8.170 Drug-induced lupus or systemic lupus erythematosus after experimental COVID-19 therapy: difficulties in differential diagnosis
- COVİD-19’UN GÜNCEL BELİRTİLERİNİN LİTERATÜR DERLEMESİ
- Therapy experience in alopecia after COVID-19